To continue providing ongoing support to new parents, UPMC has expanded its partnership with NurturePA, Inc. – a mentoring program that uses text messaging – to include both UPMC Mercy hospital and UPMC Magee-Womens Hospital.
Presenting a potentially pioneering approach to Rett syndrome, a severe chromosomal disorder that affects females, Massachusetts General Hospital (MGH) recently published study results suggesting that genetic reactivation might serve as a key to a remedy.
With a childhood history of “a gazillion sunburns” and following multiple surgeries for melanoma, Massachusetts-based writer Martha Pfeiffer qualified for a pioneering Dana-Farber Cancer Institute study isolating patients’ tumor cell DNA for personalized vaccination potential.
H. Lundbeck A/S, a Danish pharmaceutical firm focused on psychiatric and neurological treatments, recently announced its partnership with Vanderbilt University to license and advance collaborative research for treating schizophrenia cases.
Scanning, 3-D printing, laser cutting and virtual surgery simulation are among the features now functioning at Houston’s Texas Medical Center (TMC), which managing physician Dr. William “Billy” Cohn described as innovative.
Cardiac patients who received XIENCE stents reported a good quality of life and felt better sooner compared to those who underwent open-heart surgery, researchers said at a recent conference in Denver.
A Stony Brook University study carried out in tandem with Veterans Affairs (VA) medical centers recently concluded that a certain coronary bypass procedure performed without a heart-lung machine showed no benefit over conventional “on-pump” methods.
Abbott said its Confirm Rx Insertable Cardiac Monitor (ICM), a smartphone compatible ICM to help physicians identify cardiac arrhythmias remotely, has been cleared by the U.S. Food and Drug Administration (FDA).
Massachusetts General Hospital (MGH) recently said its Ammon-Pinizzotto Center for Women’s Mental Health developed an iPhone app, the MGH Perinatal Depression Scale (MGHPDS), to help change how women are screened for post-partum depression (PPD).
Abbott recently said its Proclaim DRG Neurostimulator System, which stimulates dorsal root ganglion (DRG) and eases pain in patients with complex regional pain syndrome (CRPS) of the lower limbs, has been launched in the U.S.